跳至主要内容
临床试验/NCT05691231
NCT05691231Enrolling By Invitation不适用

Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels

NuVasive2 个研究点 分布在 1 个国家目标入组 158 人开始时间: 2023年1月18日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
158
试验地点
2
主要终点
Clinical Composite Success Rate

研究概览

简要总结

A prospective, multicenter post-market clinical follow-up study to evaluate the 10-year long-term safety and effectiveness of the Simplify Disc at two levels in subjects who were enrolled in the IDE study (NCT03123549) and/or post approval study (NCT04980378).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject was enrolled in the Simplify Disc IDE (NCT03123549) and/or PAS (NCT04980378) at a participating study site
  • Patient understands the conditions of enrollment and is willing sign an informed consent form to participate in the study

排除标准

  • Subject had an SSI at the index level during the IDE study (NCT03123549) or the PAS (NCT04980378)
  • Subject was withdrawn or withdrew consent to participate in the IDE study (NCT03123549) or PAS (NCT04980378)

结局指标

主要结局

Clinical Composite Success Rate

时间窗: 10 years

Individual success is defined as at least a 15 point improvement in Neck Disability Index (NDI) Score at 120 months compared with baseline, maintenance or improvement in neurologic status at 120 months compared with baseline, no additional surgical procedure at the index level within 120 months, and the absence of a serious adverse event classified as implant-associated or implant/surgical procedure-associated within 120 months. A subject must meet each criterion to be considered an overall study success. NDI scale is reported in a range from 0 - 100, with 0 consistent with best ability to function and 100 with worst ability to function.

次要结局

  • Disc height at each annual timepoint will be compared to baseline(10 years)
  • Range of motion (ROM) at each annual timepoint compared to baseline(10 years)
  • Dysphagia Handicap Index1 (DHI) at each annual timepoint compared to baseline(10 years)
  • Adjacent level disc degeneration (ALDD) at each annual timepoint will be compared to baseline(10 years)
  • Displacement or migration of the Simplify Disc at each annual timepoint will be compared to the post-op timepoint in the IDE study (NCT03123549)(10 years)
  • Rate of adverse events attributable to Simplify Disc, or use of additional NuVasive instruments, implants, or technologies at each annual timepoint(10 years)
  • Patient satisfaction and perceived effect at each annual timepoint(10 years)
  • Motor status at each annual timepoint compared to baseline(10 years)
  • SF-36® Health Survey at each annual timepoint compared to baseline(10 years)
  • Percentage of subjects meeting the minimal clinically important difference (MCID) for NDI at each annual timepoint(10 years)
  • Percentage of subjects meeting MCID for neck and arm pain questionnaire for each of the following pain locations: neck pain, arm pain, left arm pain, right arm pain.(10 years)
  • Sensory status at each annual timepoint compared to baseline(10 years)

研究者

发起方
NuVasive
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验